Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees ...

The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing. Bio-Rad Laboratories, Inc.

Zacks Investment Research Image Source: Zacks Investment Research Digital PCR Business Backs Bio-Rad’s Growth: Bio-Rad’s QX600 ddPCR platform is currently robust and continues to expand.

Image Source: Zacks Investment Research Industry Prospects Favor Bio-Rad Per a report by Fortune Market Insights, the global ...

The SARS-CoV-2 Droplet Digital PCR (ddPCR) test runs on Bio-Rad's QX200 and QXDx ddPCR systems. The high sensitivity of the test makes it well suited to screening upper respiratory samples in patients ...

Biodesix provided data through Bio-Rad's Droplet Digital PCR technology, highlighting the significance of this research in enhancing therapeutic development and clinical care. The advancements ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit ...

The CFX96™ optical reaction module converts the C1000 Touch™ thermal cycler chassis into the powerful and precise CFX96 Touch real-time PCR detection system. This six-channel system combines ...

Led by Friends, collaborators included Biodesix alongside organizations from industry, government, academia, and advocacy ...

"Stilla’s next-generation digital PCR solutions would make a compelling and complementary addition to Bio-Rad’s best-in-class digital PCR portfolio,” said Norman Schwartz, CEO of Bio-Rad ...